Login / Signup

Chemoenzymatic Synthesis of Homogeneous Heparan Sulfate and Chondroitin Sulfate Chimeras.

Eduardo StancanelliWei LiuRylee WanderJine LiZhangjie WangKatelyn ArnoldGuowei SuAdam KanackTruong Quang PhamVijayakanth PagadalaAnand PadmanabhanYongmei XuKatelyn Arnold
Published in: ACS chemical biology (2022)
Heparan sulfate (HS) and chondroitin sulfate (CS) are two structurally distinct natural polysaccharides. Here, we report the synthesis of a library of seven structurally homogeneous HS and CS chimeric dodecasaccharides (12-mers). The synthesis was accomplished using six HS biosynthetic enzymes and four CS biosynthetic enzymes. The chimeras contain a CS domain on the reducing end and a HS domain on the nonreducing end. The synthesized chimeras display anticoagulant activity as measured by both in vitro and ex vivo experiments. Furthermore, the anticoagulant activity of H/C 12-mer 5 is reversible by protamine, a U.S. Food and Drug Administration-approved polypeptide to neutralize anticoagulant drug heparin. Our findings demonstrate the synthesis of unnatural HS-CS chimeric oligosaccharides using natural biosynthetic enzymes, offering a new class of glycan molecules for biological research.
Keyphrases
  • venous thromboembolism
  • drug administration
  • atrial fibrillation
  • cell therapy
  • sars cov
  • stem cells
  • hyaluronic acid
  • emergency department
  • risk assessment
  • coronavirus disease
  • climate change
  • water soluble